Knott David M Jr Syndax Pharmaceuticals Inc Transaction History
Knott David M Jr
- $285 Million
- Q3 2024
A detailed history of Knott David M Jr transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Knott David M Jr holds 122,144 shares of SNDX stock, worth $1.6 Million. This represents 0.83% of its overall portfolio holdings.
Number of Shares
122,144
Previous 103,826
17.64%
Holding current value
$1.6 Million
Previous $2.13 Million
10.27%
% of portfolio
0.83%
Previous 0.85%
Shares
3 transactions
Others Institutions Holding SNDX
# of Institutions
229Shares Held
88.4MCall Options Held
1.01MPut Options Held
692K-
Black Rock Inc. New York, NY7.91MShares$104 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.84MShares$76.6 Million9.23% of portfolio
-
Wellington Management Group LLP Boston, MA4.99MShares$65.4 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$64.1 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.11MShares$53.8 Million6.25% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $742M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...